John Phillips is the Executive Director, Strategy and Evaluation for the Allen Institute and is responsible for facilitating the development and execution of scientific strategy through strategic planning, integration, and evaluation of the scientific programs across the Institute’s business units. Phillips joined the Allen Institute for Brain Science in 2010 and held leadership positions in Program Management and Structured Science. He became the Executive Director of Structured Science in 2012, during which time he was responsible for leading the transformation of the Institute’s large-scale data generation teams and program/project management infrastructure to meet the goals of the Institute’s 10-year plan. Phillips has over 20 years of experience in high-throughput genomics, research operations, and drug discovery in pharmaceutical, biotechnology, and non-profit research. Prior to joining the Allen Institute, Phillips led an antibacterial drug discovery program at Merck & Co., Inc., using novel chemical genomics technology to find new lead compounds from natural product sources. Phillips also held senior leadership positions at pioneering gene expression profiling companies. He was an integral member of Acacia Biosciences, Inc., helping take the company from start-up to acquisition by Rosetta Inpharmatics, Inc., where he maintained his senior leadership position. Phillips earned a B.S. in biochemistry from University of California, Davis and a Ph.D. in biophysics from the University of California, San Francisco.